Related Experiment Video

Updated: Mar 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.6K

Cephalosporin-induced Hemolytic Anemia in a Sicilian Child

G Malaponte1, C Arcidiacono2, C Mazzarino1

  • 1a Departments of General Pathology , Via Androne 83, 95124 Catania , Italy.

Hematology (Amsterdam, Netherlands)
|July 19, 2016
PubMed

Insights

A child experienced acute hemolysis twice after cephalosporin administration, involving different immune mechanisms. This study investigates the unique immune response to cephalosporins in the child compared to family members.

Area of Science:

  • Immunology
  • Hematology
  • Pharmacology

Background:

  • Drug-induced hemolysis is a rare but serious adverse reaction.
  • Cephalosporins are a class of antibiotics known to occasionally cause hemolytic anemia.

Purpose of the Study:

  • To investigate the immunological mechanisms behind two distinct episodes of acute hemolysis in a child following cephalosporin administration.
  • To explore the differences in immune cell responses to cephalosporins between the patient, family members, and a control group.

Main Methods:

  • Case study of a 27-month-old child with recurrent acute hemolysis post-cephalosporin.
  • Analysis of hemolysis type (intravascular vs. extravascular) and associated immune mechanisms.
  • Flow cytometry analysis of lymphocyte subpopulations (CD19+, CD57+, CD8+) after in vitro cephalosporin exposure.

Main Results:

  • The first hemolytic episode was intravascular, caused by drug-antibody complexes binding to red blood cells.
  • The second episode was extravascular, likely due to antibody-dependent cell-mediated cytotoxicity.
  • Significant increases in CD19+ and CD57+ CD8+ cells were observed in the patient's lymphocytes post-cephalosporin exposure, with only CD19+ cells elevated in the father.

Conclusions:

  • Cephalosporin-induced hemolysis can manifest through different immunological pathways.
  • Distinct lymphocyte subset responses to cephalosporins may underlie individual variations in immune reactions.
  • These findings highlight potential genetic or immunological predispositions to adverse drug reactions.

Keywords:
Hemolytic anemiaantibody-dependent cell-mediated cytotoxicitycephalosporinsdirect Coombs testdrug-induced hemolysisindirect Coombs test

More Related Videos

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore09:15

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore

Published on: January 21, 2020

9.4K
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

661

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
89
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
127
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645